An aggregated analysis of hormonal factors and endometrial cancer risk by parity (Q37097950)

18 August 2017

An aggregated analysis of hormonal factors and endometrial cancer risk by parity (English)

1 reference

18 August 2017

1 reference

7

1 reference

18 August 2017

2

Patricia Hartge

1 reference

18 August 2017

3

Ruth M Pfeiffer

1 reference

18 August 2017

6

Martha S Linet

1 reference

18 August 2017

Sara J Schonfeld

1

1 reference

18 August 2017

D Michal Freedman

4

1 reference

18 August 2017

Robert T Greenlee

5

1 reference

18 August 2017

Catherine Schairer

8

1 reference

18 August 2017

Kala Visvanathan

9

1 reference

18 August 2017

James V Lacey

10

1 reference

18 August 2017

language of work or name

English

0 references

publication date

20 December 2012

1 reference

18 August 2017

1 reference

18 August 2017

119

1 reference

18 August 2017

7

1 reference

18 August 2017

1393-1401

1 reference

Long-term use of continuous-combined estrogen-progestin hormone therapy and risk of endometrial cancer

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744666

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744666

Role of progesterone in endometrial cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744666

Long-term postmenopausal hormone therapy and endometrial cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744666

Timing of births and endometrial cancer risk in Swedish women

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744666

Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses' Health Study cohort 1976-2004.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744666

Pregnancy and the risk of breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744666

Endometrial cancer and hormone-replacement therapy in the Million Women Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744666

National use of postmenopausal hormone therapy: annual trends and response to recent evidence

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744666

Cancer incidence in the US radiologic technologists health study, 1983-1998.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744666

Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744666

29 September 2017

Hormonal carcinogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744666

Two pathogenetic types of endometrial carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744666

The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744666

Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation Into Cancer and Nutrition

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744666

Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744666

Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744666

Racial/ethnic differences in endometrial cancer risk: the multiethnic cohort study.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744666

Body Mass Index, Hormone Replacement Therapy, and Endometrial Cancer Risk: A Meta-Analysis

3 September 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27909

Use of oral contraceptives and endometrial cancer risk (Sweden)

21 January 2018

2 references

https://api.crossref.org/works/10.1002%2FCNCR.27909

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3744666

Oral contraceptives and the risk of endometrial cancer

20 October 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27909

Why is Parity Protective for Uterine Fibroids?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27909

Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study

21 January 2018

1 reference

12 December 2020

Combination oral contraceptive use and the risk of endometrial cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development

1 reference

12 December 2020

Estrogen replacement therapy and the risk of endometrial cancer: remaining controversies

1 reference

12 December 2020

Reproductive factors and cancers of the breast and genital organs--are the different cancer sites similarly affected?

1 reference

12 December 2020

Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group

1 reference

12 December 2020

Oral contraceptives and endometrial cancer: do other risk factors modify the association?

1 reference

12 December 2020

Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

12 December 2020

Anthropometry, Physical Activity, and Endometrial Cancer Risk: Results From The Netherlands Cohort Study

1 reference

12 December 2020

Causes of infertility as predictors of subsequent cancer risk

1 reference

12 December 2020

Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women

1 reference

12 December 2020

Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort

1 reference

12 December 2020

Endometrial cancer associated with various forms of postmenopausal hormone therapy: a case control study

1 reference

12 December 2020

Identifiers

DOI

10.1002/CNCR.27909

1 reference

18 August 2017

1 reference

18 August 2017

1 reference